Stents Market Size, Share and Global Trend By Type (Coronary Stent, Vascular Stents, Ureteral Stent, Esophageal Stent), By Product (Dual Therapy Stents, Bioresorbable Vascular Scaffolds, Bio-engineered Stents), By Material (Non-degradable, Degradable), By Design (Coil, Helical spiral), By End User (Hospitals, Specialty Clinics), and Regional Forecast, 2024-2032

Stents are small wire mesh tubes which are used in the treatment of narrowed arteries in the body. Stents are used in opening the narrow arteries that get blocked due to fat deposition during coronary heart disease. This further helps in the reduction of symptoms associated with angina (chest pain) and helps to reduce the chances of a heart attack. The stents are made up of different materials such as metals, polymers, and plastics.

The stents are inserted inside the clogged artery and then the balloon is inflated which locks the stents in an artery as the stents get expanded. This opens the artery and helps the blood to flow more easily. Patients who undergo angioplasty using stents recovers at a faster rate than patients who undergo coronary artery bypass surgery. Growing prevalence of cardiovascular disease globally and high adoption of stents in treating coronary heart disease are likely to boost the stents market during the forecast period.

Increasing prevalence of coronary heart disease and growing awareness about the new stent implants used for the treatment for various cardiac abnormalities are the major factors likely to drive the global stents market during the projected period. In addition, growing demand for minimally invasive, effective technology, and high adoption of medical implants in treating heart diseases are anticipated to enhance the market of stents device during the forecast period.

However, due to the high cost associated with heart surgeries is likely to hamper the growth in global stents market during the forecast period.

Key Players Covered

Some of the major companies that are present in stents market are BIOTRONIK, Medtronic, BD, Boston Scientific Corporation, Abbott., Cardinal Health, Elixir Medical Corporation, Terumo Corporation, Biosensors International Group, Ltd. Meril Life Sciences Pvt. Ltd., among others.

SEGMENTATION

Among end users, hospitals are anticipated to hold the largest market share owing to the emergency visits and need for immediate heart surgeries of patients with coronary heart diseases. Coronary stents are likely to boost the growth in stents markets owing to the growing need of coronary stents in treating various cardiovascular disease. For instance, according to the recent data published by Centers for Disease Control and Prevention (CDC), it is estimated that 735,000 American populations are diagnosed with heart disease and 370,000 people die due to coronary heart disease annually and this growing prevalence of heart disease is likely to boost the stents market during the forecast period.

Key Insights

• Overview of Number of Heart Surgeries
• Epidemiology Analysis of Cardiovascular Disease
• Overview of Technological Advancement in Stents
• Pricing Analysis of Key Products
• The Regulatory Scenario for Key Countries/Regions
• Key Industry Developments – Mergers, Acquisitions, and Partnerships

Regional Analysis

Geographically, the global stents market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to hold a major portion in the global stents market during the forecast period due to the growing incidence of cardiovascular diseases and increase in the launch of effective stents devices through the acquisitions among many players. In addition, increasing expenditure in the research and development activities by leading players are likely to boost the stents device market during the forecast period. For instance, American Heart Association funds research activity related to cardiovascular disease and stroke when compared to any other organization. Stent market in the Asia Pacific is anticipated to expand the stents market at a significant rate during the analysis period owing to the increase in the patient population and growing investments in providing better healthcare infrastructure by government funded organization

Key Industry Developments

• In March 2019, BD received FDA approval to use Venovo venous stent a flexible nitinol stent which for treating iliofemoral occlusive disease by opening the blocked iliac and femoral veins in order that helps in maintaining adequate blood flow. 
• In February 2019, BIOTRONIK received FDA clearance to use Orsiro drug-eluting stent (DES) system, an ultrathin bioabsorable stent which is used in the treatment of coronary artery disease.
• In February 2019, Medtronic received FDA approval of all Resolute DES devices, including the Resolute Onyx and Resolute Integrity DES for the treatment of e novo chronic total occlusions (CTO)
• In December 2018, Medtronic received FDA approval to use Resolute Integrity Zotarolimus Eluting Coronary Stent System which is a drug coated device that is used for the treatment of a blocked coronary artery